These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33793804)
1. Oral drug delivery systems using core-shell structure additive manufacturing technologies: a proof-of-concept study. Zhang J; Xu P; Vo AQ; Repka MA J Pharm Pharmacol; 2021 Mar; 73(2):152-160. PubMed ID: 33793804 [TBL] [Abstract][Full Text] [Related]
2. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation. Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795 [TBL] [Abstract][Full Text] [Related]
4. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion. Oh HS; Park JB Int J Pharm; 2024 Aug; 661():124407. PubMed ID: 38955239 [TBL] [Abstract][Full Text] [Related]
5. Development of multifunctional drug delivery system via hot-melt extrusion paired with fused deposition modeling 3D printing techniques. Zhang Z; Feng S; Almotairy A; Bandari S; Repka MA Eur J Pharm Biopharm; 2023 Feb; 183():102-111. PubMed ID: 36632906 [TBL] [Abstract][Full Text] [Related]
6. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release. Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660 [TBL] [Abstract][Full Text] [Related]
7. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
9. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
10. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers. Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671 [TBL] [Abstract][Full Text] [Related]
11. Effect of geometry on drug release from 3D printed tablets. Goyanes A; Robles Martinez P; Buanz A; Basit AW; Gaisford S Int J Pharm; 2015 Oct; 494(2):657-663. PubMed ID: 25934428 [TBL] [Abstract][Full Text] [Related]
12. 3D extrusion printing of high drug loading immediate release paracetamol tablets. Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082 [TBL] [Abstract][Full Text] [Related]
13. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674 [TBL] [Abstract][Full Text] [Related]
14. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866 [TBL] [Abstract][Full Text] [Related]
15. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing. Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102 [TBL] [Abstract][Full Text] [Related]
16. 3D printing of immediate-release tablets containing olanzapine by filaments extrusion. Bhatt U; Malakar TK; Murty US; Banerjee S Drug Dev Ind Pharm; 2021 Aug; 47(8):1200-1208. PubMed ID: 33493008 [TBL] [Abstract][Full Text] [Related]
17. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Yang Y; Wang H; Li H; Ou Z; Yang G Eur J Pharm Sci; 2018 Mar; 115():11-18. PubMed ID: 29305984 [TBL] [Abstract][Full Text] [Related]
18. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form. Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916 [TBL] [Abstract][Full Text] [Related]
19. Development of combi-pills using the coupling of semi-solid syringe extrusion 3D printing with fused deposition modelling. Zhang B; Teoh XY; Yan J; Gleadall A; Belton P; Bibb R; Qi S Int J Pharm; 2022 Sep; 625():122140. PubMed ID: 36031167 [TBL] [Abstract][Full Text] [Related]
20. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]